Is lipoprotein-associated phospholipase A₂ correlated with cardiovascular risk in European women?
作者信息
Hirschler V
机构信息
Nutrition & Diabetes Department Hospital Durand, Buenos Aires, Argentina.
出版信息
Indian J Med Res. 2013 Dec;138(6):832-3.
Abstract
摘要
相似文献
1
Is lipoprotein-associated phospholipase A₂ correlated with cardiovascular risk in European women?
Indian J Med Res. 2013 Dec;138(6):832-3.
2
Role of secretory phospholipase A₂ in women with metabolic syndrome.
Indian J Med Res. 2013 Dec;138(6):866-72.
3
Metabolic syndrome and carotid intima-media thickness in young adults: roles of apolipoprotein B, apolipoprotein A-I, C-reactive protein, and secretory phospholipase A2: the cardiovascular risk in young Finns study.
Arterioscler Thromb Vasc Biol. 2010 Sep;30(9):1861-6. doi: 10.1161/ATVBAHA.110.204669. Epub 2010 Jun 10.
4
Inflammatory biomarkers and cardiovascular risk assessment. Current knowledge and future perspectives.
Curr Pharm Des. 2013;19(21):3827-40. doi: 10.2174/13816128113199990307.
5
Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: results from the Bruneck study.
Eur Heart J. 2009 Jan;30(1):107-15. doi: 10.1093/eurheartj/ehn502. Epub 2008 Nov 19.
6
Prognostic utility of secretory phospholipase A(2) in patients with stable coronary artery disease.
Clin Chem. 2011 Sep;57(9):1311-7. doi: 10.1373/clinchem.2011.166520. Epub 2011 Jul 22.
7
Carriers of the PCSK9 R46L Variant Are Characterized by an Antiatherogenic Lipoprotein Profile Assessed by Nuclear Magnetic Resonance Spectroscopy-Brief Report.
Arterioscler Thromb Vasc Biol. 2017 Jan;37(1):43-48. doi: 10.1161/ATVBAHA.116.307995. Epub 2016 Nov 17.
8
Phospholipase A2 enzymes, high-dose atorvastatin, and prediction of ischemic events after acute coronary syndromes.
Circulation. 2012 Feb 14;125(6):757-66. doi: 10.1161/CIRCULATIONAHA.111.063487. Epub 2012 Jan 9.
9
Novel insights of secretory phospholipase a(2) action in cardiology.
Trends Cardiovasc Med. 2009 Apr;19(3):100-3. doi: 10.1016/j.tcm.2009.06.003.
10
Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis.
Ann Rheum Dis. 2016 Oct;75(10):1806-12. doi: 10.1136/annrheumdis-2015-207872. Epub 2015 Nov 27.
本文引用的文献
1
Role of secretory phospholipase A₂ in women with metabolic syndrome.
Indian J Med Res. 2013 Dec;138(6):866-72.
2
Clinical utility of lipoprotein-associated phospholipase A₂ for cardiovascular disease prediction in a multiethnic cohort of women.
Clin Chem. 2012 Sep;58(9):1352-63. doi: 10.1373/clinchem.2012.188870. Epub 2012 Aug 2.
3
Lipid-related markers and cardiovascular disease prediction.
JAMA. 2012 Jun 20;307(23):2499-506. doi: 10.1001/jama.2012.6571.
4
Variation of lipoprotein associated phospholipase A2 across demographic characteristics and cardiovascular risk factors: a systematic review of the literature.
Atherosclerosis. 2012 Nov;225(1):11-21. doi: 10.1016/j.atherosclerosis.2012.06.020. Epub 2012 Jun 21.
5
Lipoprotein-associated phospholipase A(2) mass and activity and risk of cardiovascular disease in a population with high prevalences of obesity and diabetes: the Strong Heart Study.
Diabetes Care. 2012 Apr;35(4):840-7. doi: 10.2337/dc11-1639. Epub 2012 Feb 14.
6
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association.
Circulation. 2011 Mar 22;123(11):1243-62. doi: 10.1161/CIR.0b013e31820faaf8. Epub 2011 Feb 14.
7
Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.
Lancet. 2010 May 1;375(9725):1536-44. doi: 10.1016/S0140-6736(10)60319-4.
8
Inflammation in atherosclerosis: from pathophysiology to practice.
J Am Coll Cardiol. 2009 Dec 1;54(23):2129-38. doi: 10.1016/j.jacc.2009.09.009.
9
Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines.
Am J Cardiol. 2008 Jun 16;101(12A):51F-57F. doi: 10.1016/j.amjcard.2008.04.019.
10
Prevalence and cluster of cardiometabolic biomarkers in overweight and obese schoolchildren: results from a large survey in southwest Germany.
Clin Chem. 2008 Feb;54(2):317-25. doi: 10.1373/clinchem.2007.094821. Epub 2007 Dec 18.
Zotero 插件